BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Savira F, Magaye R, Liew D, Reid C, Kelly DJ, Kompa AR, Sangaralingham SJ, Burnett JC Jr, Kaye D, Wang BH. Cardiorenal syndrome: Multi-organ dysfunction involving the heart, kidney and vasculature. Br J Pharmacol 2020;177:2906-22. [PMID: 32250449 DOI: 10.1111/bph.15065] [Cited by in Crossref: 11] [Cited by in F6Publishing: 23] [Article Influence: 5.5] [Reference Citation Analysis]
Number Citing Articles
1 Liu X, Li Y, Ni SH, Sun SN, Deng JP, Ou-Yang XL, Huang YS, Li H, Chen ZX, Feng WJ, Lian ZM, Wang ZK, Xian SX, Yang ZQ, Ye XH, Wang LJ, Lu L. Zhen-Wu decoction and lactiflorin, an ingredient predicted by in silico modelling, alleviate uremia induced cardiac endothelial injury via Nrf2 activation. J Ethnopharmacol 2022;298:115579. [PMID: 35963415 DOI: 10.1016/j.jep.2022.115579] [Reference Citation Analysis]
2 Buliga-finis ON, Ouatu A, Badescu MC, Dima N, Tanase DM, Richter P, Rezus C. Beyond the Cardiorenal Syndrome: Pathophysiological Approaches and Biomarkers for Renal and Cardiac Crosstalk. Diagnostics 2022;12:773. [DOI: 10.3390/diagnostics12040773] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
3 Li N, Zhou G, Zheng Y, Lv D, Zhu X, Wei P, Zheng M, Liu S, Zhou E, Sun W, Zhang L. Effects of SGLT2 inhibitors on cardiovascular outcomes in patients with stage 3/4 CKD: A meta-analysis. PLoS One 2022;17:e0261986. [PMID: 35020750 DOI: 10.1371/journal.pone.0261986] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
4 Miura T, Sato T, Yano T, Takaguri A, Miki T, Tohse N, Nishizawa K. Role of Erythropoiesis-Stimulating Agents in Cardiovascular Protection in CKD Patients: Reappraisal of Their Impact and Mechanisms. Cardiovasc Drugs Ther 2022. [PMID: 35150385 DOI: 10.1007/s10557-022-07321-3] [Reference Citation Analysis]
5 Junho CVC, Trentin-Sonoda M, Panico K, Dos Santos RSN, Abrahão MV, Vernier ICS, Fürstenau CR, Carneiro-Ramos MS. Cardiorenal syndrome: long road between kidney and heart. Heart Fail Rev 2022. [PMID: 35133552 DOI: 10.1007/s10741-022-10218-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Luo S, Dou WQ, Schoepf UJ, Varga-szemes A, Pridgen WT, Zhang LJ. Cardiovascular Magnetic Resonance Imaging in Myocardial Involvement of Systemic Lupus Erythematosus. Trends in Cardiovascular Medicine 2022. [DOI: 10.1016/j.tcm.2022.02.002] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Simou A, Xanthopoulos A, Giamouzis G, Papagiannis D, Dimos A, Economou D, Skoularigis J, Triposkiadis F. Coexisting morbidity burden in elderly hospitalized patients with and without heart failure. Hellenic Journal of Cardiology 2022. [DOI: 10.1016/j.hjc.2022.02.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Ma K, Gao W, Xu H, Liang W, Ma G, Anand V. Role and Mechanism of the Renin-Angiotensin-Aldosterone System in the Onset and Development of Cardiorenal Syndrome. Journal of the Renin-Angiotensin-Aldosterone System 2022;2022:1-8. [DOI: 10.1155/2022/3239057] [Reference Citation Analysis]
9 González-Lafuente L, Navarro-García JA, Rodríguez-Sánchez E, Aceves-Ripoll J, Poveda J, Vázquez-Sánchez S, Mercado-García E, Fernández-Velasco M, Kuro-O M, Liaño F, Ruilope LM, Ruiz-Hurtado G. Interplay between mineral bone disorder and cardiac damage in acute kidney injury: from Ca2+ mishandling and preventive role of Klotho in mice to its potential mortality prediction in human. Transl Res 2022:S1931-5244(22)00002-0. [PMID: 35077866 DOI: 10.1016/j.trsl.2022.01.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
10 Zou D, Li Y, Sun G. Attenuation of Circulating Trimethylamine N-Oxide Prevents the Progression of Cardiac and Renal Dysfunction in a Rat Model of Chronic Cardiorenal Syndrome. Front Pharmacol 2021;12:751380. [PMID: 34721039 DOI: 10.3389/fphar.2021.751380] [Reference Citation Analysis]
11 She K, Li C, Qi C, Liu T, Jia Y, Zhu Y, Liu L, Wang Z, Zhang Y, Li X. Epidemiological Characteristics and Regional Risk Prediction of Hemorrhagic Fever with Renal Syndrome in Shandong Province, China. Int J Environ Res Public Health 2021;18:8495. [PMID: 34444244 DOI: 10.3390/ijerph18168495] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
12 Jíchová Š, Gawryś O, Kompanowska-Jezierska E, Sadowski J, Melenovský V, Hošková L, Červenka L, Kala P, Veselka J, Čertíková Chábová V. Kidney Response to Chemotherapy-Induced Heart Failure: mRNA Analysis in Normotensive and Ren-2 Transgenic Hypertensive Rats. Int J Mol Sci 2021;22:8475. [PMID: 34445179 DOI: 10.3390/ijms22168475] [Reference Citation Analysis]
13 Junho CVC, Azevedo CAB, da Cunha RS, de Yurre AR, Medei E, Stinghen AEM, Carneiro-Ramos MS. Heat Shock Proteins: Connectors between Heart and Kidney. Cells 2021;10:1939. [PMID: 34440708 DOI: 10.3390/cells10081939] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
14 Wu C, Yan F, Li M, Tu Y, Guo Z, Chen Y, Wu Y, Li Q, Yu C, Fu Y, Wu M, Kong W, Gao Y, Li X, Zheng J. Whole-Mount Kidney Clearing and Visualization Reveal Renal Sympathetic Hyperinnervation in Heart Failure Mice. Front Physiol 2021;12:696286. [PMID: 34305650 DOI: 10.3389/fphys.2021.696286] [Reference Citation Analysis]
15 Díez J, Navarro-gonzález JF, Ortiz A, Santamaría R, de Sequera P. Developing the subspecialty of cardio-nephrology: The time has come. A position paper from the coordinating committee from the Working Group for Cardiorenal Medicine of the Spanish Society of Nephrology. Nefrología (English Edition) 2021;41:391-402. [DOI: 10.1016/j.nefroe.2021.02.010] [Reference Citation Analysis]
16 Efentakis P, Molitor M, Kossmann S, Bochenek ML, Wild J, Lagrange J, Finger S, Jung R, Karbach S, Schäfer K, Schulz A, Wild P, Münzel T, Wenzel P. Tubulin-folding cofactor E deficiency promotes vascular dysfunction by increased endoplasmic reticulum stress. Eur Heart J 2021:ehab222. [PMID: 34132336 DOI: 10.1093/eurheartj/ehab222] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
17 Díez J, Navarro-González JF, Ortiz A, Santamaría R, de Sequera P. Developing the subspecialty of cardio-nephrology: The time has come. A position paper from the coordinating committee from the Working Group for Cardiorenal Medicine of the Spanish Society of Nephrology. Nefrologia 2021;41:391-402. [PMID: 33892978 DOI: 10.1016/j.nefro.2021.02.003] [Reference Citation Analysis]
18 Peterson SJ, Choudhary A, Kalsi AK, Zhao S, Alex R, Abraham NG. OX-HDL: A Starring Role in Cardiorenal Syndrome and the Effects of Heme Oxygenase-1 Intervention. Diagnostics (Basel) 2020;10:E976. [PMID: 33233550 DOI: 10.3390/diagnostics10110976] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
19 Saito Y. The role of the PlGF/Flt-1 signaling pathway in the cardiorenal connection. J Mol Cell Cardiol 2021;151:106-12. [PMID: 33045252 DOI: 10.1016/j.yjmcc.2020.10.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
20 Kalra S, Aydin H, Sahay M, Ghosh S, Ruder S, Tiwaskar M, Kilov G, Kishor K, Nair T, Makkar V, Unnikrishnan AG, Dhanda D, Gupta N, Srinivasan B, Kumar A. Cardiorenal Syndrome in Type 2 Diabetes Mellitus - Rational Use of Sodium-glucose Cotransporter-2 Inhibitors. Eur Endocrinol 2020;16:113-21. [PMID: 33117442 DOI: 10.17925/EE.2020.16.2.113] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
21 Savira F, Kompa AR, Edgley AJ, Jucker BM, Willette RN, Kelly DJ, Wang BH. RE: ASK1, a new target in treating cardiorenal syndrome (CRS). Int J Cardiol 2020;316:207. [PMID: 32891263 DOI: 10.1016/j.ijcard.2020.05.050] [Reference Citation Analysis]
22 Momtazmanesh S, Shobeiri P, Hanaei S, Mahmoud-Elsayed H, Dalvi B, Malakan Rad E. Cardiovascular disease in COVID-19: a systematic review and meta-analysis of 10,898 patients and proposal of a triage risk stratification tool. Egypt Heart J 2020;72:41. [PMID: 32661796 DOI: 10.1186/s43044-020-00075-z] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 10.5] [Reference Citation Analysis]
23 Savira F, Magaye R, Liew D, Reid C, Kelly DJ, Kompa AR, Sangaralingham SJ, Burnett JC Jr, Kaye D, Wang BH. Cardiorenal syndrome: Multi-organ dysfunction involving the heart, kidney and vasculature. Br J Pharmacol 2020;177:2906-22. [PMID: 32250449 DOI: 10.1111/bph.15065] [Cited by in Crossref: 11] [Cited by in F6Publishing: 23] [Article Influence: 5.5] [Reference Citation Analysis]